Publications 2026

Heggebø LC, Hellebust TP, Henry T, Fjæra LF, Ottestad A, Rylander H, Hervani M, Evensen ME, Gustafsson M, Blakstad H, Sprauten M, Magelssen H, Moorthy J, Andersson KM, Dahlgren CV, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Bergström P, Agrup M, Kinhult S, Alkner S, Dahl L et al. (2026)
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries
Clin Transl Radiat Oncol, 60, 101220
DOI 10.1016/j.ctro.2026.101220, PubMed 42383068

Publications 2025

Heggebø LC, Garrote FLB, Fjæra LF, Hervani M, Ramberg C, Ottestad A, Blakstad H, Martens T, Rueegg CS, Gustavsson M, Henry T, Blomstrand M, Hellebust TP, Brandal P (2025)
Protons or Photons in Pituitary Neuroendocrine Tumors-That Is Not the Question
Int J Part Ther, 17, 101194
DOI 10.1016/j.ijpt.2025.101194, PubMed 40678408

Svestad JG, Mikalsen SG, Heydari M, Francke RH, Hervani M, Hellebust TP (2025)
Setup Accuracy and Efficiency of Real-Time Video Assistance for Surface-Guided Positioning in Radiation Therapy of Right-Sided Locoregional Breast Cancer
Adv Radiat Oncol, 10 (9), 101829
DOI 10.1016/j.adro.2025.101829, PubMed 40757180

Publications 2023

Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
BMJ Open, 13 (3), e070071
DOI 10.1136/bmjopen-2022-070071, PubMed 36940951